Global VMS CDMO Market Size Likely to Surpass at a CAGR of 9% By 2034

Market Size and Growth

As per the VMS CDMO Market size analysis conducted by the CMI Team, the global Vms cdmo Market is expected to record a CAGR of 9% from 2025 to 2034. In 2025, the market size is projected to reach a valuation of USD 42.1 Billion. By 2034, the valuation is anticipated to reach USD 97.5 Billion.

Overview

According to industry experts, the VMS CDMO is growing as consumers switch to preventive care and tailored nutrition. The increased need for immunity boosters, clean-label supplements, and functional nutrition is driving brands to collaborate with CDMOs to achieve speed, compliance, and innovation. The automation, digital quality, and advanced formulation capabilities are being incorporated by the manufacturers. Despite the high growth rate, price sensitivity, ingredient shortages, and regulatory complexity are some of the challenges.

Key Trends & Drivers

• Increasing Health Consciousness and Preventive Health Lifestyle: Globally, consumers are spending a lot on immunity boosting, gut health, and nutritional supplementation. The increasing lifestyle diseases and the growing aged population increase the demand for vitamins, minerals, and supplements. CDMOs provide brands with quicker product launches, cost effectiveness, and compliance. The individualized nutrition and increased use of clean-label formulations contribute to further development of the sector in the long term.

• Trend to Outsourcing and Flexible Manufacturing: Supplement companies are outsourcing more and more formulation, R&D, pilot batches, and manufacturing operations to CDMOs in the hopes of lowering costs of capital and enhancing flexibility. Developed technologies are gummies, effervescents, softgels, and functional powders offered by CDMOs. Their ability to scale up quickly and complicated recipes generates high demand in the world market.

• Growth of E-Commerce and Escape of Functional Nutrition: The growth of online retailing will allow online supplement brands to acquire a global market with a minimum of physical facilities. The advantages of CDMOs are that they help the brands diversify with such categories as plant-based nutrition, sports supplements, and herbal extracts. The wellness programs on subscription and the influence of influencers speed up the adoption of the products and boost the volume of orders among the contract manufacturers.

Report Scope

SWOT Analysis

• Strengths: CDMOs have knowledge on regulatory compliance, formulation science, and fast commercialization. Global supplement brands are enticed by their diversified competencies in terms of the format of delivery and ingredients. They lower the operational expenses of their clients and allow clients to innovate faster, raising the overall market competitiveness and expansion.

• Weaknesses: The volatility in prices of raw materials, disruption in the supply chain, and reliance on the suppliers are operational risks. Differences between regions in regulations make compliance more difficult. The smaller CDMOs are not that technologically advanced and do not have global certifications, which restricts competition. Delays to timely delivery may also be caused by capacity limitations during the peak seasons of demand.

• Opportunities: The opportunities are in high growth in personalized nutrition, clean-label supplements, botanical formulations, and sports nutrition. Bringing in APAC, MEA and LATAM will offer unexploited demand. The opportunities for differentiation of CDMOs are through innovations in bioavailability, encapsulation, and new delivery systems.

• Threats: The market will be threatened by counterfeit supplements, strict international laws, and price competition. Demand may be influenced by shortages of ingredients, geopolitical risks, and changing consumer trends. Smaller players may face a challenge posed by competition from vertically integrated brands and the global CDMOs.

List of the prominent players in the VMS CDMO Market:

• Lonza
• Thermo Fisher Scientific
• Catalent
• WuXi AppTec
• WuXi Biologics
• Samsung Biologics
• AGC Biologics
• FUJIFILM Diosynth Biotechnologies
• Charles River Laboratories
• Recipharm
• Boehringer Ingelheim (CDMO)
• Rentschler Biopharma
• Siegfried
• KBI Biopharma
• Novasep
• Aldevron
• Andelyn Biosciences
• Oxford Biomedica
• IDT Biologika
• Grand River Aseptic Manufacturing
• Others

The VMS CDMO Market is segmented as follows:

By Product Type

• Vitamins
• Minerals
• Others

By Formulation

• Tablets
• Capsules
• Powders
• Liquids & Syrups
• Others

By Distribution Channel

• Direct-to-Consumer (D2C) Brands
• Retail Brands & Pharma Companies
• Private Label Companies
• Online Supplement Companies
• Others

By End User

• Dietary Supplement Companies
• Pharmaceutical Companies
• Sports Nutrition Brands
• Functional Food & Beverage Companies
• Others

Regional Coverage:

North America

• U.S.
• Canada
• Mexico
• Rest of North America

Europe

• Germany
• France
• U.K.
• Russia
• Italy
• Spain
• Netherlands
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• New Zealand
• Australia
• South Korea
• Taiwan
• Rest of Asia Pacific

The Middle East & Africa

• Saudi Arabia
• UAE
• Egypt
• Kuwait
• South Africa
• Rest of the Middle East & Africa

Latin America

• Brazil
• Argentina
• Rest of Latin America